However, CLL cells have different BCR pathways compared to physiological B lymphocytes: ZAP-70 is a protein that, when overexpressed in CLL cells, enhances BCR signaling, acting as an adapter protein rather than its kinase activity [72,73]. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.